Analysed Gain Therapeutics Inc (GANX:NASDAQ) News Sources
Why Celldex Therapeutics, Inc.’s (CLDX) Stock Is Up 16.38%
American Association of Individual Investors
Anika Therapeutics Inc.: Anika Reports Fourth Quarter and Full Year 2025 Financial Results
FinanzNachrichten.de
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Markets Insider
What is the current price of Gain Therapeutics Inc (GANX:NASDAQ)?
The current price of Gain Therapeutics Inc (GANX:NASDAQ) is $2.455.
Gain Therapeutics Inc (GANX:NASDAQ) absolute price change since previous trading day?
The absolute price change of Gain Therapeutics Inc (GANX:NASDAQ) since the previous trading day is $-0.06.
Gain Therapeutics Inc (GANX:NASDAQ) percentage price change since previous trading day?
The percentage price change of Gain Therapeutics Inc (GANX:NASDAQ) since the previous trading day is -2.58%.
What is This Week's average sentiment score for Gain Therapeutics Inc (GANX:NASDAQ)?
This Week's average sentiment score for Gain Therapeutics Inc (GANX:NASDAQ) is 63 out of 100.
What is This Week's average sentiment for Gain Therapeutics Inc (GANX:NASDAQ)?
This Week's sentiment for Gain Therapeutics Inc (GANX:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.